AbCellera Biologics Cash Flow Statement (2020-2026) | ABCL

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-2.32M-21.38M59.95M168.57M-6.79M26.62M-29.89M-40.11M-30.53M-28.61M-47.15M-40.61M-36.93M-51.11M-34.21M-45.62M-34.73M-57.12M-8.95M-43.16M
Depreciation and Depletion (Quarter)
1.10M1.20M1.34M1.39M2.30M2.50M2.74M2.86M3.00M3.10M3.86M3.15M3.40M3.80M2.06M4.41M4.50M4.30M5.10M5.92M
Share-based Compensation (Quarter)
8.47M7.71M9.04M12.29M12.11M11.75M13.32M15.47M16.40M15.86M16.45M17.41M17.78M17.16M15.23M14.79M14.21M13.89M12.90M12.01M
Deferred Taxes (Quarter)
0.13M-4.02M1.25M
Gains from Sales and Divestitures (Quarter)
0.04M0.06M0.19M
Gains from Investment Securities (Quarter)
0.26M0.21M3.22M8.32M2.29M2.51M-23.11M4.47M2.20M3.54M3.48M5.91M2.29M27.69M-35.89M-2.21M2.88M6.22M-3.56M-2.38M
Non-cash Items (Quarter)
18.05M17.96M0.10M0.46M20.71M0.93M113.40M
Cash from Operations (Quarter)
157.68M-5.93M-16.71M100.22M273.01M-126.79M30.91M-44.06M19.90M-0.11M-19.61M-41.71M-29.97M-28.88M-8.00M-11.55M-32.40M-52.59M-34.74M-33.52M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-1.11M0.54M8.17M0.98M1.14M1.57M15.20M1.61M3.71M2.67M3.65M1.69M33.07M-29.95M73.50M0.92M0.93M3.00M1.80M0.92M
Depreciation & Amortization (CF) (Quarter)
1.10M1.20M1.34M1.39M2.30M2.50M2.74M2.86M3.00M3.10M3.86M3.15M3.40M3.80M2.06M4.41M4.50M4.30M5.10M5.92M
Change in Working Capital
Change in Receivables (Quarter)
-1.73M5.99M3.06M8.75M-1.79M-3.29M19.04M-7.92M32.18M11.23M10.44M18.58M15.86M19.82M20.86M1.13M11.39M3.43M39.67M-13.10M
Change in Account Payables (Quarter)
3.49M3.33M-4.32M0.75M27.30M-29.20M2.22M-5.78M-10.47M14.40M-4.88M4.75M0.13M
Change in Accured Expenses (Quarter)
-4.88M4.75M4.15M6.62M-3.41M-3.95M5.07M5.74M-9.41M
Change in Taxes (Quarter)
-24.21M0.77M16.03M69.97M-17.71M-87.19M-53.67M-12.61M35.50M5.80M1.78M-3.18M-2.77M-2.76M15.36M-4.41M-3.18M-12.20M-10.05M-4.97M
Other Working Capital Changes (Quarter)
-1.24M-1.06M4.84M7.56M-3.42M-8.23M5.47M-3.90M-0.96M0.55M-13.93M3.60M-16.39M11.77M-4.95M-7.32M16.68M-23.44M-3.07M1.74M
Investing Activities
Capital Expenditures (Quarter)
36.80M8.57M9.43M14.49M31.32M12.51M12.33M14.98M27.20M20.33M14.43M24.14M20.11M18.52M15.63M10.64M13.37M8.93M9.84M3.83M
Change in Intangibles (Quarter)
Change in Acquisitions & Divestments (Quarter)
18.08M57.29M88.51M272.43M92.39M262.64M160.18M220.10M268.02M306.55M232.84M196.60M201.89M190.03M113.41M83.10M119.54M143.80M
Cash from Investing Activities (Quarter)
-45.63M-269.63M-1.15M-26.37M-27.20M-281.99M-17.06M-149.61M-34.39M-12.79M-24.32M29.91M52.10M3.70M35.70M7.93M-31.81M36.49M75.14M-25.08M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)
-5.08M0.90M1.83M-3.13M1.17M-0.02M0.35M-0.46M0.42M6.63M3.77M2.83M2.65M3.15M4.14M5.97M-3.38M7.37M4.12M7.19M
Additional items
Exchange Rate Effect (Quarter)
-0.20M-0.22M-0.53M-0.20M-1.21M-8.55M0.36M-0.21M0.80M-1.06M1.07M-0.78M-0.04M0.37M-2.16M0.59M0.76M-0.54M0.29M-0.04M
Change in Cash (Quarter)
106.78M-274.88M-16.55M70.51M245.78M-417.35M14.56M-194.34M-13.27M-7.33M-39.10M-9.75M24.74M-21.67M29.68M2.94M-66.83M-9.28M44.80M-51.45M
Free Cash Flow (Quarter)
120.88M-14.51M-26.14M85.72M241.69M-139.30M18.58M-59.05M-7.30M-20.44M-34.04M-65.85M-50.08M-47.40M-23.63M-22.19M-45.77M-61.52M-44.59M-37.35M
Net Cash Flow (Quarter)
106.97M-274.66M-16.03M70.72M246.99M-408.80M14.20M-194.13M-14.07M-6.26M-40.17M-8.97M24.78M-22.04M31.84M2.35M-67.59M-8.73M44.51M-51.41M